| PERSONALIS INC. DL-,001 |
| USA |
| Gesundheit |
| US71535D1063 / A2PLTK |
| 04X (Frankfurt) / PSNL (NASDAQ) |
| FRA:04X, ETR:04X, 04X:GR, NASDAQ:PSNL |
| - |
| https://www.personalis.co.. |
|
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of..
>Volltext.. |
| 1426.25 Mio. EUR |
| 1257.93 Mio. EUR |
| 56.4 Mio. EUR |
| -81.03 Mio. EUR |
| -83.53 Mio. EUR |
| -0.89 EUR |
| 33.9 Mio. EUR |
| 64.33 Mio. EUR |
| -69.46 Mio. EUR |
| 5.97 |
| -29.51% |
| -6.43% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 4.455.012 Euro. |
| PERSONALIS |
| 21.07.26 |
|